Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 17/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 14/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6621734 | 0.92 | GRIN2B (0.45) | GRIN2BGRIN1BRD4PDGFRBPDGFRA | |
| SCHEMBL6615232 | 0.91 | ALDH1A1 (0.46) | GRIN2BGRIN1BRD4PDGFRBPDGFRA | |
| SCHEMBL6619419 | 0.84 | PDGFRB (0.47) | GRIN2BBRD4PDGFRBPDGFRAKDM4E | |
| SCHEMBL6615147 | 0.82 | KDM4E (0.42) | GRIN2BGRIN1PDGFRBPDGFRAKDM4E | |
| SCHEMBL9053527 | 0.82 | BRD4 (0.41) | GRIN2BGRIN1BRD4PDGFRBPDGFRA | |
| SCHEMBL6621978 | 0.81 | PDGFRB (0.45) | GRIN2BBRD4PDGFRBPDGFRAKDM4E | |
| Dimethylamine SCHEMBL6616891 | 0.81 | PDGFRB (0.45) | GRIN2BBRD4PDGFRBPDGFRAKDM4E | |
| SCHEMBL6620040 | 0.81 | PDGFRB (0.50) | GRIN2BPDGFRBPDGFRAKDM4ENPC1 | |
| SCHEMBL6621864 | 0.81 | PDGFRB (0.44) | GRIN2BBRD4PDGFRBPDGFRAKDM4E | |
| SCHEMBL6618297 | 0.81 | PDGFRB (0.44) | GRIN2BBRD4PDGFRBPDGFRAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0779889-B1 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | AVENTIS PHARMA INC (US) | 2004-06-23 | — | — | EP | disclosed |
| EP-0779889-A4 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE POULENC RORER PHARMA (US) | 2000-02-23 | — | — | EP | disclosed |
| EP-0779889-A1 | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-06-25 | — | — | EP | disclosed |
| WO-1996007658-A1 | PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-03-14 | — | — | WO | disclosed |
| US-5476851-A | Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1995-12-19 | — | — | US | disclosed |